Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to an uncharacterized molecular component within the nervous system of ectoparasites such as Sarcoptes scabiei (mites) and Pediculus humanus (lice). While the specific protein or receptor has not been definitively identified in pharmacological literature, it serves as the functional site of action for traditional acaricides and pediculicides like benzyl benzoate and crotamiton. These compounds are believed to disrupt the normal physiological processes of the parasite's nervous system, resulting in overstimulation or paralysis. This disruption ultimately leads to the death of the organism, facilitating the treatment of conditions such as scabies and pediculosis. Because the target is not fully defined at the molecular level, it is often categorized generically in drug databases as a component of the parasite's nervous system.
The exact molecular mechanism is unknown, but these agents act as scabicides and pediculicides by exerting toxic effects on the nervous system of the parasites, leading to paralysis and death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unidentified molecular component of the nervous system of mites and lice.